PRSS1 and familial pancreatic carcinoma: Thus, development of pancreatic cancer was not restricted to PRSS1-asociated HP, but was also found in patients with SPINK1 germline mutations, suggesting that long-term inflammation and existing CP involving hyperplasia and metaplasia of the pancreatic duct epithelium, not the mutations alone, increase the risk of pancreatic cancer.